Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

Kantarjian H, Giles F, Wunderle L, Bhalla K, O'Brien S, Wassmann B, Tanaka C, Manley P, Rae P, Mietlowski W, Bochinski K, Hochhaus A, Griffin JD, Hoelzer D, Albitar M, Dugan M, Cortes J, Alland L, Ottmann OG

Open source

DOI: 10.1056/nejmoa055104
Published: 2006 Jun 15
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa055104,
  title = {Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.},
  author = {Kantarjian H and Giles F and Wunderle L and Bhalla K and O'Brien S and Wassmann B and Tanaka C and Manley P and Rae P and Mietlowski W and Bochinski K and Hochhaus A and Griffin JD and Hoelzer D and Albitar M and Dugan M and Cortes J and Alland L and Ottmann OG},
  year = {2006},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa055104},
  url = {https://doi.org/10.1056/nejmoa055104}
}

RIS

TY  - JOUR
TI  - Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.
AU  - Kantarjian H
AU  - Giles F
AU  - Wunderle L
AU  - Bhalla K
AU  - O'Brien S
AU  - Wassmann B
AU  - Tanaka C
AU  - Manley P
AU  - Rae P
AU  - Mietlowski W
AU  - Bochinski K
AU  - Hochhaus A
AU  - Griffin JD
AU  - Hoelzer D
AU  - Albitar M
AU  - Dugan M
AU  - Cortes J
AU  - Alland L
AU  - Ottmann OG
PY  - 2006
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa055104
UR  - https://doi.org/10.1056/nejmoa055104
ER  -

APA

H, K., F, G., L, W., K, B., S, O., B, W., C, T., P, M., P, R., W, M., K, B., A, H., JD, G., D, H., M, A., M, D., J, C., L, A., & OG, O. (2006). Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.. The New England journal of medicine. https://doi.org/10.1056/nejmoa055104

Source records

pubmed · retrieved 2026-09-25T01:21:21.106Z